Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-010035
Filing Date
2025-03-24
Accepted
2025-03-24 16:24:14
Documents
21
Period of Report
2025-05-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20046009x1_pre14a.htm   iXBRL PRE 14A 2037834
3 logo_immunocore.jpg GRAPHIC 29929
4 ny20046009x1_barchart01.jpg GRAPHIC 123474
5 ny20046009x1_linechart01.jpg GRAPHIC 257497
6 ny20046009x1_pvpchart01.jpg GRAPHIC 205861
7 ny20046009x1_pvpchart02.jpg GRAPHIC 185502
8 ny20046009x1_pc01.jpg GRAPHIC 1468205
9 ny20046009x1_pc02.jpg GRAPHIC 1076690
  Complete submission text file 0001140361-25-010035.txt   11827499

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA imcr-20250515.xsd EX-101.SCH 2137
23 EXTRACTED XBRL INSTANCE DOCUMENT ny20046009x1_pre14a_htm.xml XML 300391
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39992 | Film No.: 25764462
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)